Generating pluripotent stem cells: Differential epigenetic changes during cellular reprogramming Journal Article


Authors: Tobin, S. C.; Kim, K.
Article Title: Generating pluripotent stem cells: Differential epigenetic changes during cellular reprogramming
Abstract: Pluripotent stem cells hold enomous potential for therapuetic applications in tissue replacement therapy. Reprogramming somatic cells from a patient donor to generate pluripotent stem cells involves both ethical concerns inherent in the use of embryonic and oocyte-derived stem cells, as well as issues of histocompatibility. Among the various pluripotent stem cells, induced pluripotent stem cells (iPSC) - derived by ectopic expression of four reprogramming factors in donor somatic cells - are superior in terms of ethical use, histocompatibility, and derivation method. However, iPSC also show genetic and epigenetic differences that limit their differentiation potential, functionality, safety, and potential clinical utility. Here, we discuss the unique characteristics of iPSC and approaches that are being taken to overcome these limitations. © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Keywords: stem cell; differentiation; reprogramming; epigenetic; ipsc; esc; ntesc; pesc
Journal Title: FEBS Letters
Volume: 586
Issue: 18
ISSN: 0014-5793
Publisher: Wiley Blackwell  
Date Published: 2012-08-31
Start Page: 2874
End Page: 2881
Language: English
DOI: 10.1016/j.febslet.2012.07.024
PROVIDER: scopus
PUBMED: 22819821
PMCID: PMC3589521
DOI/URL:
Notes: --- - "Export Date: 4 September 2012" - "CODEN: FEBLA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kitai Kim
    13 Kim
  2. Stacey C Tobin
    2 Tobin